HGF: dosing and handling
Human schedule
Controlled data on this compound are limited. The regimens below were gathered from public sources online (studies and protocols) and are given as a reference, not a usage plan.
HGF (hepatocyte growth factor) is a large protein administered parenterally in studies, mainly as an intravenous infusion; this is a generalized reference from the limited clinical and preclinical data.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Phase I/II clinical (IV infusion ~3 h, daily 12–14 days) | 0.6 mg/m² per day | Only studied dose |
| Planned escalation in the same protocol | up to 1.2–2.4 mg/m² per day | Not reached in the trial |
| Preclinical reference (rats, SC / IM / IV) | 0.25–2.5 mg/kg | Preclinical data only |